Bristol-Myers: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Amylin Pharmaceuticals (AMLM) initiated at Credit Suisse with an Outperform rating and $28 price target. Analysts noted improved confidence in Byetta and potential acquisition interest. 2010 and 2011 EPS estimates set at -$0.75 and -$0.10, respectively.

AOL (AOL) rated new Hold at Jefferies.$27 price target. Company is re-inventing itself, but lacks near-term catalysts.

Dell (DELL) upgraded at UBS from Neutral to Buy. $16 price target. Valuation call, as gross margins have bottomed.

Kimberly-Clark (KMB) downgraded at Goldman from Neutral to Sell. Estimates also lowered, because of higher expected pulp prices. New $60 price target.

Micron Technology (MU) downgraded at UBS from Buy to Neutral. $10.50 price target. Estimates also lowered, because of market oversupply.

MSCI (MXB) upgraded at UBS from Neutral to Buy. Stock has fallen 14% since mid-December, though the RiskMetrics acquisition should add to earnings. $40 price target.

OSI Pharmaceuticals (OSIP) downgraded at UBS from Buy to Neutral. $56 price target. Roche bid is unlikely, but the stock is already pricing in the majority of the takeover premium.

OSI Pharmaceuticals (OSIP) target upped at Goldman to $48. Hostile bid has helped boost the value. Neutral rating.

Rowan (RDC) downgraded at MKM from Buy to Neutral. Valuation call, as the stock is up 21% since late January.

Shanda Interactive (SNDA) downgraded at Roth from Buy to Hold. $48 price target. Company has limited earnings visibility, following the recent profit miss.

Sandisk (SNDK) upgraded at UBS from Sell to Neutral. $34 price target. Estimates also raised, as pricing should improve along with handset storage growth.

Southern Union (SUG) downgraded at Stifel from Buy to Hold. Stock is already pricing in strength in the Gathering and Processing segment.

Westar Energy (WR) upgraded at Wells to Outperform. Estimates also raised, because of expected base rate relief.

Exco Resources (XCO) initiated at Barclays with an Overweight rating and $29 price target. 2010 could mark the beginning of an aggressive growth profile driven by the Haynesville and Marcellus shale plays.

STOCK COMMENTS / EPS CHANGES

Boeing (BA) 2011 EPS estimates introduced at $5.10, 2010 maintained at $4.40. Reiterate Overweight rating and $65 target.